CSIMarket
 


Taro Pharmaceutical Industries Ltd  (TARO)
Other Ticker:  
 
 

TARO's EPS Net Growth by Quarter and Year

Taro Pharmaceutical Industries Ltd's EPS Net results by quarter and year




TARO EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.68 1.55 -10.12 6.35
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.68 1.55 -10.12 6.35



TARO EPS Net fourth quarter 2023 Y/Y Growth Comment
Taro Pharmaceutical Industries Ltd reported drop in EPS Net in the fourth quarter 2023 by -56.13% to $ 0.68 , from the same quarter in 2022.
The fall in the fourth quarter 2023 Taro Pharmaceutical Industries Ltd's EPS Net compares unfavorably to the Company's average EPS Net decline of -42.57%.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher EPS Net growth. While Taro Pharmaceutical Industries Ltd' s EPS Net meltdown of -56.13% ranks overall at the positon no. 469 in the fourth quarter 2023.




TARO EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -56.13 % - - -12.17 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -56.13 % - - -12.17 %

Financial Statements
Taro Pharmaceutical Industries Ltd's fourth quarter 2023 EPS Net $ 0.68 TARO's Income Statement
Taro Pharmaceutical Industries Ltd's fourth quarter 2022 EPS Net $ 1.55 Quarterly TARO's Income Statement
New: More TARO's historic EPS Net Growth >>


TARO EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -56.13 % - - -12.17 %




EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #25
Overall #469

EPS Net Y/Y Growth Statistics
High Average Low
38.94 % -42.57 % -259.37 %
(Mar 31 2015)   (Mar 31 2021)
EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #25
Overall #469
EPS Net Y/Y Growth Statistics
High Average Low
38.94 % -42.57 % -259.37 %
(Mar 31 2015)   (Mar 31 2021)

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Taro Pharmaceutical Industries Ltd's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TARO's IV. Quarter Q/Q EPS Net Comment


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TARO's IV. Quarter Q/Q EPS Net Comment


Taro Pharmaceutical Industries Ltd's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
0
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Mar 31 2021)
12 Months Ending
0
Cumulative EPS Net 12 Months Ending $ 0.68 $ 0.00 $ 1.55 $ -10.12 $ 0.00
Y / Y EPS Net Growth (TTM) -56.13 % - - - -
Year on Year EPS Net Growth Overall Ranking # 470 # 0 # 0 # 0 # 1713
Seqeuential EPS Net Change (TTM) -56.13 % - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # 470 # 0 # 0 # 0 # 1713




Cumulative EPS Net growth Comment
Taro Pharmaceutical Industries Ltd showed decline, but improvement compare to trailing twelve month EPS Net decrease in 0. If the fiscal year would end in Mar 31 2023, Taro Pharmaceutical Industries Ltd's annual EPS Net drop would be -56.13% year on year to $1 .

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 0 to 470.

EPS Net TTM Q/Q Growth Statistics
High Average Low
38.94 %
-42.57 %
-259.37 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 25
Overall # 470

EPS Net TTM Y/Y Growth Statistics
High Average Low
38.94 %
-42.57 %
-259.37 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 25
S&P 500 # 470
Cumulative EPS Net growth Comment
Taro Pharmaceutical Industries Ltd showed decline, but improvement compare to trailing twelve month EPS Net decrease in 0. If the fiscal year would end in Mar 31 2023, Taro Pharmaceutical Industries Ltd's annual EPS Net drop would be -56.13% year on year to $1 .

Within the Healthcare sector 24 other companies have achieved higher trailing twelve month EPS Net growth. While EPS Net growth total ranking has deteriorated compare to previous quarter from 0 to 470.

EPS Net TTM Q/Q Growth Statistics
High Average Low
38.94 %
-42.57 %
-259.37 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 25
Overall # 470

EPS Net TTM Y/Y Growth Statistics
High Average Low
38.94 %
-42.57 %
-259.37 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 25
S&P 500 # 470




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
TARO's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for TARO's Competitors
EPS Net Growth for Taro Pharmaceutical Industries Ltd's Suppliers
EPS Net Growth for TARO's Customers

You may also want to know
TARO's Annual Growth Rates TARO's Profitability Ratios TARO's Asset Turnover Ratio TARO's Dividend Growth
TARO's Roe TARO's Valuation Ratios TARO's Financial Strength Ratios TARO's Dividend Payout Ratio
TARO's Roa TARO's Inventory Turnover Ratio TARO's Growth Rates TARO's Dividend Comparisons



Companies with similar EPS Net drop for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2023
Charles River Laboratories International inc -1.31%$ -1.311 
Encompass Health Corporation-3.73%$ -3.731 
Regeneron Pharmaceuticals Inc -4.07%$ -4.066 
Haemonetics Corporation-4.69%$ -4.688 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.78%$ -8.778 
Avenue Therapeutics Inc -11.55%$ -11.547 
Gilead Sciences Inc -11.97%$ -11.969 
Utah Medical Products Inc-14.08%$ -14.084 
Masimo Corp-18.55%$ -18.550 
Merit Medical Systems Inc-18.93%$ -18.927 
Qiagen N v -19.57%$ -19.565 
Avantor Inc -22.62%$ -22.616 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Star Equity Holdings Inc -29.22%$ -29.218 
Harmony Biosciences Holdings inc -38.72%$ -38.717 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Pro dex Inc -41.67%$ -41.667 
Embecta Corp -42.62%$ -42.623 
Becton Dickinson And Company-43.53%$ -43.529 
Bio techne Corp-45.16%$ -45.161 
Amgen Inc -52.98%$ -52.977 
Biogen Inc -55.59%$ -55.590 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com